Glaxo 387
Generic Name: cefuroxime
Pill imprint Glaxo 387 has been identified as Ceftin 250 mg.
Ceftin is used in the treatment of urinary tract infection; bacterial infection; bladder infection; bronchitis; sinusitis (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy.
Ceftin 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Ceftin Images
- Generic Name:
- cefuroxime
- Imprint:
-
Glaxo
387 - Strength:
- 250 mg
- Color:
- Blue
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
hypromelloses
methylparaben
microcrystalline cellulose
propylene glycol
propylparaben
sodium benzoate
sodium lauryl sulfate
titanium dioxide
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0387
Advertisement
More Ceftin resources
- Ceftin
- Ceftin (Wolters Kluwer)
- Ceftin Suspension (Wolters Kluwer)
- Ceftin (Cerner Multum)
- Ceftin (Micromedex) - Includes Dosage Information
- Ceftin (FDA)
- Ceftin Tablets, Oral Suspension (FDA)
Ceftin is associated with the treatment of:
- Bacterial Infection
- Bladder Infection
- Bone infection
- Bronchitis
- Epiglottitis
- Gonococcal Infection, Disseminated
- Gonococcal Infection, Uncomplicated
- Impetigo
- Joint Infection
- Kidney Infections
- Lyme Disease
- Meningitis
- Otitis Media
- Peritonitis
- Pneumonia
- Sepsis
- Sinusitis
- Skin and Structure Infection
- Skin Infection
- Strep Throat
- Surgical Prophylaxis
- Tonsillitis/Pharyngitis
- Upper Respiratory Tract Infection
- Urinary Tract Infection
Search Again
